Send Inquiry

Request To Call Back

REDITUX RITUXIMAB INJECTION

Get a Price/Quote

REDITUX RITUXIMAB INJECTION Specification

Salt Composition
Rituximab

Indication
Cancer treatment and certain autoimmune diseases

Origin of Medicine
Biological

Dosage Form
Liquid solution for infusion

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Biological, Anticancer

Ingredients
Rituximab

Physical Form
Injection

Function
Monoclonal antibody therapy; targets CD20 antigen on B-lymphocytes

Recommended For
Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis

Dosage
As directed by physician

Dosage Guidelines
Administered intravenously under medical supervision

Suitable For
Adults

Quantity
100 mg/10 ml or 500 mg/50 ml vial

Storage Instructions
Store in a refrigerator (2C 8C). Do not freeze.

Handling Precautions
Handle by qualified healthcare professionals only

Common Side Effects
Infusion reactions, fever, chills, infections, hypotension, hematological toxicity

Contraindications
Hypersensitivity to rituximab or murine proteins, severe infections

Warning
Not to be administered as IV push or bolus

Prescription Required
Yes

Strength
100 mg/10 ml or 500 mg/50 ml

Shelf Life
24 months from date of manufacture

Route of Administration
Intravenous infusion

Concentration
10 mg/ml

Colour
Colourless to pale yellow

Other Information
Refer to full prescribing information before use

Brand Name
Reditux

ATC Code
L01XC02

REDITUX RITUXIMAB INJECTION Trade Information

Packaging Details
PACK OF 1 VIAL

Main Domestic Market
All India

About REDITUX RITUXIMAB INJECTION

Specification

Contains:Rituximab
Form:Vial
Strength:100mg & 500 mg single dose vial
Packing:Pack of 1 Vial

NOTE: Reditux is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug............

How Reditux Rituximab Works

Reditux is a monoclonal antibody designed to attach to the CD20 antigen on B-lymphocytes. By targeting these cells, the medication helps the immune system to eliminate abnormal B-lymphocytes in conditions like lymphoma, leukemia, or autoimmune disorders, contributing to effective disease management.

Usage and Administration Process

Reditux is supplied as a liquid solution requiring intravenous infusion under direct medical supervision. Dosage and frequency depend on the specific condition and patients clinical status, determined by the physician. It is not suitable for IV push or bolus; infusions must be carefully monitored for infusion-related reactions.

Storage and Handling Precautions

This biological anticancer injection should be stored in a refrigerator between 2C and 8C, never frozen. Only qualified healthcare professionals are authorized to handle and prepare the infusion. Reditux comes in single vials per box, ensuring proper dosage accuracy and minimizing contamination risks.

FAQs of REDITUX RITUXIMAB INJECTION:

Q: What conditions is Reditux Rituximab Injection commonly used to treat?

A: Reditux is indicated for cancer treatment, particularly Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia, as well as for certain autoimmune diseases such as Rheumatoid Arthritis.

Q: How is Reditux administered to patients?

A: Reditux is given through intravenous infusion in a medical setting under the supervision of qualified healthcare professionals. It should never be injected as an IV push or bolus.

Q: When should Reditux not be administered?

A: Reditux should not be used in cases of known hypersensitivity to rituximab, murine proteins, or in patients with severe active infections. Always consult the full prescribing information for detailed contraindications.

Q: What are common side effects associated with Reditux?

A: Patients may experience infusion reactions, fever, chills, infections, hypotension, or hematological toxicity. Close monitoring during and after infusion is recommended to manage these effects promptly.

Q: Where should Reditux Rituximab Injection be stored?

A: Vials should be kept in a refrigerator at 2C to 8C and must never be frozen to maintain the stability and efficacy of the drug.

Q: What precautions should healthcare professionals take while handling Reditux?

A: Handling and preparation should only be conducted by qualified personnel, observing safety guidelines to avoid accidental exposure and ensure patient safety.

Q: What are the benefits of using Reditux in eligible patients?

A: Reditux targets and helps remove abnormal B-lymphocytes, offering significant therapeutic advantages in hematological malignancies and autoimmune conditions, supporting improved disease control and overall outcomes.

Tell us about your requirement